Playing the Devil’s Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? – ie Strategies to Revert Resistance to mTOR Inhibitors

Pezzicoli G, Filoni E, Gernone A, Cosmai L, Rizzo M, Porta C

Cancer Management and Research 2021, 13:7623-7636

Published Date: 4 October 2021